{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:10:59Z","timestamp":1789096259990,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-83921-3","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T21:29:39Z","timestamp":1735853379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The multi-target mechanism of action of Selaginella doederleinii Hieron in the treatment of nasopharyngeal carcinoma: a network pharmacology and multi-omics analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Huaguo","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caifu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"issue":"10192","key":"83921_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen, Y. P. et al. Nasopharyngeal carcinoma. Lancet 394(10192), 64\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(19)30956-0 (2019).","journal-title":"Lancet"},{"issue":"1","key":"83921_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2016.01.040","volume":"374","author":"LL Tang","year":"2016","unstructured":"Tang, L. L. et al. Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett. 374(1), 22\u201330. https:\/\/doi.org\/10.1016\/j.canlet.2016.01.040 (2016).","journal-title":"Cancer Lett."},{"issue":"4","key":"83921_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2020.12.007","volume":"32","author":"P Bossi","year":"2021","unstructured":"Bossi, P. et al. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Ann. Oncol. 32(4), 452\u2013465. https:\/\/doi.org\/10.1016\/j.annonc.2020.12.007 (2021).","journal-title":"Ann. Oncol."},{"issue":"5","key":"83921_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/cancers16050918","volume":"16","author":"L Suryani","year":"2024","unstructured":"Suryani, L. et al. Precision medicine for nasopharyngeal cancer\u2014A review of current prognostic strategies. Cancers (Basel) 16(5), 918. https:\/\/doi.org\/10.3390\/cancers16050918 (2024).","journal-title":"Cancers (Basel)"},{"issue":"03","key":"83921_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1142\/S0192415X24500253","volume":"52","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Traditional Chinese medicine for cancer treatment. Am. J. Chin. Med. 52(03), 583\u2013604. https:\/\/doi.org\/10.1142\/S0192415X24500253 (2024).","journal-title":"Am. J. Chin. Med."},{"key":"83921_CR6","first-page":"831","volume-title":"Dictionary of Traditional Chinese medicine","author":"Nanjing University of Chinese Medicine","year":"2006","unstructured":"Nanjing University of Chinese Medicine. Dictionary of Traditional Chinese medicine 831\u2013832 (Shanghai Science and Technology Press, 2006)."},{"key":"83921_CR7","volume-title":"Pharmacopoeia of People\u2019s Republic of China Part 1","author":"CP Commission","year":"2020","unstructured":"Commission, C. P. Pharmacopoeia of People\u2019s Republic of China Part 1 (China Medical Science Press, 2020)."},{"issue":"6","key":"83921_CR8","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3390\/antiox11061189","volume":"11","author":"FW Muema","year":"2022","unstructured":"Muema, F. W., Liu, Y., Zhang, Y., Chen, G. & Guo, M. Flavonoids from Selaginella doederleinii Hieron and their antioxidant and antiproliferative activities. Antioxidants (Basel) 11(6), 1189. https:\/\/doi.org\/10.3390\/antiox11061189 (2022).","journal-title":"Antioxidants (Basel)"},{"issue":"12","key":"83921_CR9","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/ph15121505","volume":"15","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. A biflavonoid-rich extract from Selaginella doederleinii Hieron. against throat carcinoma via Akt\/Bad and IKK\u03b2\/NF-\u03baB\/COX-2 pathways. Pharmaceuticals (Basel) 15(12), 1505. https:\/\/doi.org\/10.3390\/ph15121505 (2022).","journal-title":"Pharmaceuticals (Basel)"},{"issue":"11","key":"83921_CR10","doi-asserted-by":"publisher","first-page":"e18442","DOI":"10.1111\/jcmm.18442","volume":"28","author":"HY Jian","year":"2024","unstructured":"Jian, H. Y., Zhang, J. T., Liu, Z., Zhang, Z. & Zeng, P. H. Amentoflavone reverses epithelial-mesenchymal transition in hepatocellular carcinoma cells by targeting p53 signalling pathway axis. J. Cell Mol. Med. 28(11), e18442. https:\/\/doi.org\/10.1111\/jcmm.18442 (2024).","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"83921_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/molecules22020325","volume":"22","author":"H Yao","year":"2017","unstructured":"Yao, H. et al. Analysis of the total biflavonoids extract from Selaginella doederleinii by HPLC-QTOF-MS and its in vitro and in vivo anticancer effects. Molecules 22(2), 325. https:\/\/doi.org\/10.3390\/molecules22020325 (2017).","journal-title":"Molecules"},{"key":"83921_CR12","doi-asserted-by":"publisher","first-page":"565090","DOI":"10.3389\/fphar.2020.565090","volume":"11","author":"S Li","year":"2020","unstructured":"Li, S. et al. Ethyl acetate extract of Selaginella doederleinii Hieron induces cell autophagic death and apoptosis in colorectal cancer via PI3K-Akt-mTOR and AMPK\u03b1-signaling pathways. Front. Pharmacol. 11, 565090. https:\/\/doi.org\/10.3389\/fphar.2020.565090 (2020).","journal-title":"Front. Pharmacol."},{"key":"83921_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jep.2016.06.029","volume":"190","author":"Y Sui","year":"2016","unstructured":"Sui, Y. et al. Ethyl acetate extract from Selaginella doederleinii Hieron inhibits the growth of human lung cancer cells A549 via caspase-dependent apoptosis pathway. J. Ethnopharmacol. 190, 261\u2013271. https:\/\/doi.org\/10.1016\/j.jep.2016.06.029 (2016).","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"83921_CR14","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4314\/ajtcam.v10i6.17","volume":"10","author":"R Lian","year":"2013","unstructured":"Lian, R. et al. Effect of ethanol extract of Selaginella doederleinii Hieron on the proliferation of nasopharyngeal carcinoma CNE-1 and C666\u20131 cells. Afr. J. Tradit. Complement. Altern. Med. 10(6), 490\u2013493. https:\/\/doi.org\/10.4314\/ajtcam.v10i6.17 (2013).","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"issue":"1","key":"83921_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jep.2011.08.072","volume":"138","author":"H Liu","year":"2011","unstructured":"Liu, H. et al. Reactive oxygen species-mediated mitochondrial dysfunction is involved in apoptosis in human nasopharyngeal carcinoma CNE cells induced by Selaginella doederleinii extract. J. Ethnopharmacol. 138(1), 184\u2013191. https:\/\/doi.org\/10.1016\/j.jep.2011.08.072 (2011).","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"83921_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","volume":"43","author":"C Nogales","year":"2022","unstructured":"Nogales, C. et al. Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol. Sci. 43(2), 136\u2013150. https:\/\/doi.org\/10.1016\/j.tips.2021.11.004 (2022).","journal-title":"Trends Pharmacol. Sci."},{"key":"83921_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.semcancer.2020.12.020","volume":"84","author":"N J\u00e4ger","year":"2022","unstructured":"J\u00e4ger, N. Bioinformatics workflows for clinical applications in precision oncology. Semin. Cancer Biol. 84, 103\u2013112. https:\/\/doi.org\/10.1016\/j.semcancer.2020.12.020 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"83921_CR18","doi-asserted-by":"publisher","first-page":"116306","DOI":"10.1016\/j.jep.2023.116306","volume":"309","author":"L Zhao","year":"2023","unstructured":"Zhao, L. et al. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J. Ethnopharmacol. 309, 116306. https:\/\/doi.org\/10.1016\/j.jep.2023.116306 (2023).","journal-title":"J. Ethnopharmacol."},{"issue":"11","key":"83921_CR19","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41422-020-0374-x","volume":"30","author":"YP Chen","year":"2020","unstructured":"Chen, Y. P. et al. Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma. Cell Res. 30(11), 1024\u20131042. https:\/\/doi.org\/10.1038\/s41422-020-0374-x (2020).","journal-title":"Cell Res."},{"issue":"1","key":"83921_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 9(1), 559. https:\/\/doi.org\/10.1186\/1471-2105-9-559 (2008).","journal-title":"BMC Bioinform."},{"key":"83921_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132, 19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001 (2015).","journal-title":"SoftwareX"},{"issue":"16","key":"83921_CR22","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel, D. et al. GROMACS: Fast, flexible, and free. J. Comput. Chem. 26(16), 1701\u20131718. https:\/\/doi.org\/10.1002\/jcc.20291 (2005).","journal-title":"J. Comput. Chem."},{"issue":"3","key":"83921_CR23","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10555-024-10176-9","volume":"43","author":"ZY Su","year":"2024","unstructured":"Su, Z. Y., Siak, P. Y., Lwin, Y. Y. & Cheah, S. C. Epidemiology of nasopharyngeal carcinoma: current insights and future outlook. Cancer Metastasis Rev. 43(3), 919\u2013939. https:\/\/doi.org\/10.1007\/s10555-024-10176-9 (2024).","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"83921_CR24","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1186\/s12967-023-04673-8","volume":"21","author":"PY Siak","year":"2023","unstructured":"Siak, P. Y., Heng, W. S., Teoh, S. S. H., Lwin, Y. Y. & Cheah, S. C. Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect. J. Transl. Med. 21(1), 786. https:\/\/doi.org\/10.1186\/s12967-023-04673-8 (2023).","journal-title":"J. Transl. Med."},{"issue":"2","key":"83921_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/pca.2478","volume":"25","author":"S Li","year":"2014","unstructured":"Li, S. et al. Preparative isolation of six anti-tumour biflavonoids from Selaginella doederleinii Hieron by high-speed counter-current chromatography. Phytochem. Anal. 25(2), 127\u2013133. https:\/\/doi.org\/10.1002\/pca.2478 (2014).","journal-title":"Phytochem. Anal."},{"key":"83921_CR26","doi-asserted-by":"publisher","first-page":"101097","DOI":"10.1016\/j.mam.2022.101097","volume":"86","author":"S Pan","year":"2022","unstructured":"Pan, S. & Chen, R. Pathological implication of protein post-translational modifications in cancer. Mol. Aspects Med. 86, 101097. https:\/\/doi.org\/10.1016\/j.mam.2022.101097 (2022).","journal-title":"Mol. Aspects Med."},{"issue":"2","key":"83921_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","volume":"22","author":"O Hassin","year":"2023","unstructured":"Hassin, O. & Oren, M. Drugging p53 in cancer: one protein, many targets. Nat. Rev. Drug Discov. 22(2), 127\u2013144. https:\/\/doi.org\/10.1038\/s41573-022-00571-8 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"83921_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","volume":"21","author":"M Yi","year":"2022","unstructured":"Yi, M. et al. Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions. Mol. Cancer 21(1), 28. https:\/\/doi.org\/10.1186\/s12943-021-01489-2 (2022).","journal-title":"Mol. Cancer"},{"issue":"1","key":"83921_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","volume":"28","author":"D Kaloni","year":"2023","unstructured":"Kaloni, D., Diepstraten, S. T., Strasser, A. & Kelly, G. L. BCL-2 protein family: attractive targets for cancer therapy. Apoptosis 28(1), 20\u201338. https:\/\/doi.org\/10.1007\/s10495-022-01780-7 (2023).","journal-title":"Apoptosis"},{"key":"83921_CR30","doi-asserted-by":"publisher","first-page":"188569","DOI":"10.1016\/j.bbcan.2021.188569","volume":"1","author":"L Zhang","year":"1876","unstructured":"Zhang, L. & Lu, Z. Zhao X (2021) targeting Bcl-2 for cancer therapy. Biochim. Biophys. Acta Rev. Cancer 1, 188569. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188569 (1876).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"83921_CR31","doi-asserted-by":"publisher","first-page":"114747","DOI":"10.1016\/j.bcp.2021.114747","volume":"193","author":"S Iliaki","year":"2021","unstructured":"Iliaki, S. et al. Polo-like kinase 1 (PLK1) signaling in cancer and beyond. Biochem. Pharmacol. 193, 114747. https:\/\/doi.org\/10.1016\/j.bcp.2021.114747 (2021).","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"83921_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13046-023-02872-1","volume":"42","author":"R Xu","year":"2023","unstructured":"Xu, R. et al. Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1. J. Exp. Clin. Cancer Res. 42(1), 302. https:\/\/doi.org\/10.1186\/s13046-023-02872-1 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"83921_CR33","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/s41419-022-05478-1","volume":"13","author":"TT Zeng","year":"2022","unstructured":"Zeng, T. T. et al. HN1L\/AP-2\u03b3\/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma. Cell Death Dis. 13(12), 1026. https:\/\/doi.org\/10.1038\/s41419-022-05478-1 (2022).","journal-title":"Cell Death Dis."},{"key":"83921_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.mrrev.2014.02.005","volume":"761","author":"H Yim","year":"2014","unstructured":"Yim, H. & Erikson, R. L. Plk1-targeted therapies in TP53- or RAS-mutated cancer. Mutat. Res. Rev. Mutat. Res. 761, 31\u201339. https:\/\/doi.org\/10.1016\/j.mrrev.2014.02.005 (2014).","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"issue":"1","key":"83921_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/ijms20010039","volume":"20","author":"SK Chiang","year":"2019","unstructured":"Chiang, S. K., Chen, S. E. & Chang, L. C. A dual role of heme oxygenase-1 in cancer cells. Int. J. Mol. Sci. 20(1), 39. https:\/\/doi.org\/10.3390\/ijms20010039 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"83921_CR36","doi-asserted-by":"publisher","first-page":"658315","DOI":"10.3389\/fimmu.2021.658315","volume":"31","author":"KN Luu Hoang","year":"2021","unstructured":"Luu Hoang, K. N., Anstee, J. E. & Arnold, J. N. The diverse roles of heme oxygenase-1 in tumor progression. Front. Immunol. 31(12), 658315. https:\/\/doi.org\/10.3389\/fimmu.2021.658315 (2021).","journal-title":"Front. Immunol."},{"issue":"11","key":"83921_CR37","doi-asserted-by":"publisher","first-page":"e133929","DOI":"10.1172\/jci.insight.133929","volume":"5","author":"E Alaluf","year":"2020","unstructured":"Alaluf, E. et al. Heme oxygenase-1 orchestrates the immunosuppressive program of tumor-associated macrophages. JCI Insight 5(11), e133929. https:\/\/doi.org\/10.1172\/jci.insight.133929 (2020).","journal-title":"JCI Insight"},{"issue":"12","key":"83921_CR38","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1002\/ijc.34270","volume":"151","author":"S Magri","year":"2022","unstructured":"Magri, S. et al. The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients. Int. J. Cancer 151(12), 2265\u20132277. https:\/\/doi.org\/10.1002\/ijc.34270 (2022).","journal-title":"Int. J. Cancer"},{"issue":"21","key":"83921_CR39","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.3390\/cancers13215498","volume":"13","author":"S Putti","year":"2021","unstructured":"Putti, S., Giovinazzo, A., Merolle, M., Falchetti, M. L. & Pellegrini, M. ATM kinase dead: From ataxia telangiectasia syndrome to cancer. Cancers (Basel) 13(21), 5498. https:\/\/doi.org\/10.3390\/cancers13215498 (2021).","journal-title":"Cancers (Basel)"},{"issue":"4","key":"83921_CR40","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/path.5018","volume":"244","author":"RWM Lung","year":"2018","unstructured":"Lung, R. W. M. et al. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma. J. Pathol. 244(4), 394\u2013407. https:\/\/doi.org\/10.1002\/path.5018 (2018).","journal-title":"J. Pathol."},{"key":"83921_CR41","doi-asserted-by":"publisher","first-page":"113216","DOI":"10.1016\/j.ejmech.2021.113216","volume":"213","author":"MM Madkour","year":"2021","unstructured":"Madkour, M. M., Anbar, H. S. & El-Gamal, M. I. Current status and future prospects of p38\u03b1\/MAPK14 kinase and its inhibitors. Eur. J. Med. Chem. 213, 113216. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113216 (2021).","journal-title":"Eur. J. Med. Chem."},{"issue":"19","key":"83921_CR42","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1158\/0008-5472.CAN-15-0173","volume":"75","author":"A Igea","year":"2015","unstructured":"Igea, A. & Nebreda, A. R. The stress kinase p38\u03b1 as a target for cancer therapy. Cancer Res. 75(19), 3997\u20134002. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0173 (2015).","journal-title":"Cancer Res."},{"issue":"17","key":"83921_CR43","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.3390\/cancers15174236","volume":"15","author":"KT Skinner","year":"2023","unstructured":"Skinner, K. T., Palkar, A. M. & Hong, A. L. Genetics of ABCB1 in cancer. Cancers (Basel) 15(17), 4236. https:\/\/doi.org\/10.3390\/cancers15174236 (2023).","journal-title":"Cancers (Basel)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83921-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83921-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83921-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T15:03:56Z","timestamp":1735916636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83921-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["83921"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-83921-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}